International Scholarly Research Notices

Clinical Study

The Effects of Continuous Blood Purification for SIRS/MODS Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Table 1

Baseline characteristics of the included studies.


Trials	Sample size ()	Country	Disease	Illness severity scores	Age	Filter membrane	Blood flow (mL/min)	Treatment

Sander 1997 [6]	13/13	Germany	SIRS			AN69	150 mL/min	CVVH* versus control
Sanchez Riera 1997 [7, 8]	15/15	Spain	MODS	^A		AN69	130 mL/min	CVVH* versus control
Cole et al. 2002 [9]	12/12	Australia	MODS	^A	Median (IQR) 65.5 (22.0)/ 68.0 (19.0)	AN69	200 mL/min	CVVH* versus control
Liu et al. 2003 [10]	24/26	China	MODS	^A		AN69 +PS	200–250 mL/min	CVVH* versus control
Yang et al. 2004 [11]	22/15	China	SIRS	^A		PS	150–200 mL/min	CVVH* versus control
Ding and Zhao 2007 [12]	11/10	China	MODS	^A	23–78/23–78	PS	Not reported	CVVH* versus control
Yang and Hoyang 2008 [13]	31/27	China	SIRS	^A		PS	180–250 mL/min	CVVH* versus control
Peng et al. 2008 [14]	17/15	China	SIRS	^A	28–70/30–69	AN69	250–300 mL/min	CVVH* versus control
Zhang et al. 2006 [15]	30/30	China	SIRS	Not reported		PS	150–200 mL/min	CVVH* versus control
Payen et al. 2009 [16]	37/39	France	SIRS	^B		PS	150 mL/min	CVVH* versus control

MODS: multiple-organ dysfunction syndrome.
SIRS: systemic inflammatory response syndrome.
CVVH* group: CVVH + conventional therapeutic measures.
Control group: conventional therapeutic measures.
A: acute physiology and chronic health evaluation, APACHE II score; B: simplified acute physiology score, SOFA score.